Skip to search formSkip to main contentSkip to account menu

EG 626

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
7-Ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626) (0.3-3 mg/kg i.v.), a new cyclic AMP phosphodiesterase… 
1980
1980
Effects of Phthalazinol (EG 626), a cyclic AMP phosphodiesterase inhibitor, a thromboxane A2 antagonist and an… 
1980
1980
To enhance the biostability of the ester linkage of 7-ethoxycarbonyl-4-hydroxymethyl-1(2H)-phthalazinone, which has potent… 
1979
1979
Phthalazinol (EG 626), a thromboxane A2 antagonist and cyclic AMP phosphodiesterase inhibitor, has been shown to prevent the… 
1979
1979
Effects of phthalazinol, EG 626, on the membrane and mechanical properties of the vascular smooth muscles, namely superior… 
1977
1977
Sticking and aggregation of platelets to the damaged or denuded endothelial surface of atheromatous plaque are common findings in…